Invitalia Ventures
VC Fund
Rome, Italy
Invitalia Ventures is a VC fund in Rome focused on Software and Medical. Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation. Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it
- Total investments:
- 30
- Last investment:
- Lead investor:
- 13%
- Fund size:
- $103M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Invitalia Ventures invests in
Stages Invitalia Ventures invests in
Countries Invitalia Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $292–$1.6M
- Series A
- $900k–$6.2M
Investment Focus
Industry
- Software 6 (20%)
- Medical 5 (17%)
- B2B 3 (10%)
- Health Care 3 (10%)
- Biotechnology 3 (10%)
Stage
- Series A 9 (30%)
- Seed 6 (20%)
- Funding Round 4 (13%)
- Venture - Series Unknown 4 (13%)
- Series B 1 (3%)
Country
- Italy 19 (63%)
- United States 2 (7%)
- United Kingdom 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Domenico Arcuri
Chief Executive Officer & Board Member
|
Chief Executive Officer & Board Member | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| The ESG Rating platform for every company | $570.9K / Debt Financing / May 01, 2021 | ||
| Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers. | $6.6M / Apr 09, 2020 | ||
| BigProfiles is an Artificial Intelligence Platform designed for Utilities, Telcos, Banks, Insurance companies and Retails.Large companies such as Teleperformance, Eni, Unicef already have already successfully subscribed to our services.BigProfiles is the No-Code Artificial Intelligence Platform for sales and antichurn that predicts thelikelihood to purchase and churn of each customer in a CRM, before proceeding to contact him in a sales or retention campaign. | $1.6M / Feb 10, 2020 | ||
| BigProfiles is an Artificial Intelligence Platform designed for Utilities, Telcos, Banks, Insurance companies and Retails.Large companies such as Teleperformance, Eni, Unicef already have already successfully subscribed to our services.BigProfiles is the No-Code Artificial Intelligence Platform for sales and antichurn that predicts thelikelihood to purchase and churn of each customer in a CRM, before proceeding to contact him in a sales or retention campaign. | $2.5M / Series A / Feb 10, 2020 | ||
| 2Hire offers mobility solutions by turning all kind of vehicles into connected cars. By equipping vehicles with 2Hire plug and play device, all vehicles' actions are performed remotely by smartphone thanks to their software. Real-time data analysis enhances fleet management and the full exploitation of available resources. | $6.2M / Series A / Feb 04, 2020 | ||
| D-Orbit is an Italian New Space company providing solutions for satellite design, development, launch, commissioning and decommissioning. Founded in 2011, D-Orbit currently employs approximately 35 people. The firm is based in Milan, Italy with subsidiaries in Washington, DC, and Lisbon, Portugal. D-Orbit's business model revolves aroundproducts and services that are profitable, create value for the customer, and have a proven social benefit and a positive impact on the environment. To do so, we look for ways to streamline every phase of a satellite mission with components and services that simplify spacecraft design, increase reliability, improve the use of mission resources, reduce operational costs, and extend the revenue-generating phase of a space mission. | Series C / Dec 19, 2019 | ||
| D-Orbit is an Italian New Space company providing solutions for satellite design, development, launch, commissioning and decommissioning. Founded in 2011, D-Orbit currently employs approximately 35 people. The firm is based in Milan, Italy with subsidiaries in Washington, DC, and Lisbon, Portugal. D-Orbit's business model revolves aroundproducts and services that are profitable, create value for the customer, and have a proven social benefit and a positive impact on the environment. To do so, we look for ways to streamline every phase of a satellite mission with components and services that simplify spacecraft design, increase reliability, improve the use of mission resources, reduce operational costs, and extend the revenue-generating phase of a space mission. | Series B / Dec 18, 2019 | ||
| Kither Biotech is a pharmaceutical product company that focuses its R&D activities on the development of new drugs. The R&D activities of the company mainly involve the development of new drugs to treat chronic inflammatory diseases.In recent years Kither has focused its first line of activities on the development of a small peptide(KIT2014) developed internally for the treatment of cystic fibrosis, a disease that predominantly affects the lungs and that currently has no cure. The KIT2014 peptide was assigned the Orphan Drug designation from the European Medicines Agency. The KIT2014 compound is currently undergoing the pre-clinical phase of clinical development.Kither’s product portfolio also includes a molecule (CL27), also developed internally, that is being developed for the treatment of Chronic Obstructive Pulmonary Diseases and Allergic Asthma. The company is about to start the pre-clinical phase of development of the CL27 molecule. | $6.1M / Series A / Jul 05, 2019 | ||
| Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers. | $2.7M / Jun 17, 2019 | ||
| Mindesk is a Real-Time 3D design platform that integrates with existing commercial CAD software to extend its operations to Virtual Reality and Augmented Reality. Mindesk introduces the possibility to design a CAD project from scratch in Virtual Reality. Mindesk platform integrates directly with current CAD solutions and saves precious designsteps: while the majority of VR CAD software commercially available require document exportation, Mindesk enables users to switch from VR to desktop seamlessly while editing the project in real-time on either platform. | $900K / Series A / Mar 12, 2019 | ||
| See all 30 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Invitalia Ventures invest in?
Invitalia Ventures invests primarily in Software, Medical and B2B startups, most often at Series A and Seed stage. Most of the 30 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Invitalia Ventures's check size?
Invitalia Ventures typically joins rounds of $292–$1.6M at Seed and $900k–$6.2M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Invitalia Ventures participates in.
How do I contact Invitalia Ventures?
Public channels for Invitalia Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Invitalia Ventures?
The team at Invitalia Ventures includes Domenico Arcuri (Chief Executive Officer & Board Member). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
